CD19 and systemic sclerosis: Furthermore, an altered B cell system has been described demonstrating that B cells play an important role in the pathogenesis of SSc [16]: Autoimmune properties of B cells are increased in SSc patients by an overexpression of CD19 [17] and B cell activating factor (BAFF) [18].